Biocon gets DCGI nod to market biosimilar trastuzumab in India

Biocon today said it has received approval from the Indian drug regulator to market its biosimilar trastuzumab developed jointly with Mylan.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news